BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1393 related articles for article (PubMed ID: 12965983)

  • 21. Costs and effects of ultrasonography in the evaluation of palpable breast masses.
    Flobbe K; Kessels AG; Severens JL; Beets GL; de Koning HJ; von Meyenfeld MF; van Engelshoven JM
    Int J Technol Assess Health Care; 2004; 20(4):440-8. PubMed ID: 15609793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotaxic needle-core biopsy and fine-needle aspiration biopsy in the diagnosis of nonpalpable breast lesions: controversies and future prospects.
    Lifrange E; Kridelka F; Colin C
    Eur J Radiol; 1997 Jan; 24(1):39-47. PubMed ID: 9056148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonpalpable, well-defined, probably benign breast nodule: management by fine-needle aspiration biopsy and long-interval follow-up mammography.
    Apesteguía L; Pina L; Inchusta M; Mellado M; Franquet T; De Miguel C; López-Cousillas A; Repáraz B
    Eur Radiol; 1997; 7(8):1235-9. PubMed ID: 9377508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasound-guided fine-needle aspiration (FNA) of nonpalpable breast lesions: a review of 1885 FNA cases using the National Cancer Institute-supported recommendations on the uniform approach to breast FNA.
    Boerner S; Fornage BD; Singletary E; Sneige N
    Cancer; 1999 Feb; 87(1):19-24. PubMed ID: 10096355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of fine-needle aspiration in the evaluation of persistent palpable dominant breast masses.
    Hindle WH; Payne PA; Pan EY
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1814-8; discussion 1818-9. PubMed ID: 8317526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preoperative needle biopsy: an improvement in palpable breast tumors with strong indications for malignancy].
    Zonderland HM; van de Velde CJ; van de Vijver MJ; Hermans J
    Ned Tijdschr Geneeskd; 1996 Sep; 140(39):1952-6. PubMed ID: 8927182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neddle-guided biopsy in the diagnosis of non-palpable breast cancer].
    Becerra-Alcántara GI; Círigo-Villagómez LL; Ramos-Medina F; Robledo-Martínez H; Mar-Merinos CG; Panzi-Altamirano RM
    Ginecol Obstet Mex; 2015 Jul; 83(7):400-7. PubMed ID: 26422910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of diagnosis and surgical management of breast lesions in a community hospital: room for improvement?
    Hanley C; Kessaram R
    Can J Surg; 2006 Jun; 49(3):185-92. PubMed ID: 16749979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of ultrasonography and fine-needle aspiration cytology to the differential diagnosis of palpable solid breast lesions.
    Reinikainen HT; Rissanen TJ; Piippo UK; Päivänsalo MJ
    Acta Radiol; 1999 Jul; 40(4):383-9. PubMed ID: 10394865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective evaluation of the value of combined mammographic and sonographic assessment in patients with palpable abnormalities of the breast.
    Shetty MK; Shah YP; Sharman RS
    J Ultrasound Med; 2003 Mar; 22(3):263-8; quiz 269-70. PubMed ID: 12636326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Palpable Breast Lump With Recent Negative Mammogram: Is Repeat Mammography Necessary?
    Leung SE; Ben-Nachum I; Kornecki A
    AJR Am J Roentgenol; 2016 Jul; 207(1):200-4. PubMed ID: 27081707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histologic work-up of non-palpable breast lesions classified as probably benign at initial mammography and/or ultrasound (BI-RADS category 3).
    Gruber R; Jaromi S; Rudas M; Pfarl G; Riedl CC; Flöry D; Graf O; Sickles EA; Helbich TH
    Eur J Radiol; 2013 Mar; 82(3):398-403. PubMed ID: 22429299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal mammography and ultrasonography in the setting of palpable breast cancer.
    Beyer T; Moonka R
    Am J Surg; 2003 May; 185(5):416-9. PubMed ID: 12727559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of US-guided fine-needle aspiration with on-site cytopathologic evaluation in management of nonpalpable breast lesions.
    Buchbinder SS; Gurell DS; Tarlow MM; Salvatore M; Suhrland MJ; Kader K
    Acad Radiol; 2001 Apr; 8(4):322-7. PubMed ID: 11293780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of malignancy in palpable solid breast masses considered probably benign or low suspicion: implications for management.
    Giess CS; Smeglin LZ; Meyer JE; Ritner JA; Birdwell RL
    J Ultrasound Med; 2012 Dec; 31(12):1943-9. PubMed ID: 23197547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of palpable breast lesions in younger women by the modified triple test is accurate and cost-effective.
    Vetto JT; Pommier RF; Schmidt WA; Eppich H; Alexander PW
    Arch Surg; 1996 Sep; 131(9):967-72; discussion 972-4. PubMed ID: 8790167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The diagnostic role of breast echography].
    Ciatto S; Rosselli del Turco M; Catarzi S; Morrone D; Bonardi R
    Radiol Med; 1994 Sep; 88(3):221-4. PubMed ID: 7938725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specificity of mammography and US in the evaluation of a palpable abnormality: retrospective review.
    Moy L; Slanetz PJ; Moore R; Satija S; Yeh ED; McCarthy KA; Hall D; Staffa M; Rafferty EA; Halpern E; Kopans DB
    Radiology; 2002 Oct; 225(1):176-81. PubMed ID: 12355002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Level of suspicion of a mammographic lesion: use of features defined by BI-RADS lexicon and correlation with large-core breast biopsy.
    Bérubé M; Curpen B; Ugolini P; Lalonde L; Ouimet-Oliva D
    Can Assoc Radiol J; 1998 Aug; 49(4):223-8. PubMed ID: 9709675
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 70.